UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019636
Receipt number R000022695
Scientific Title Relationship between eyelid pressure and dry eye in patients with thyroid eye disease, ptosis, or facial nerve palsy.
Date of disclosure of the study information 2015/11/10
Last modified on 2023/11/10 10:03:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between eyelid pressure and dry eye in patients with thyroid eye disease, ptosis, or facial nerve palsy.

Acronym

Relationship between eyelid pressure and dry eye

Scientific Title

Relationship between eyelid pressure and dry eye in patients with thyroid eye disease, ptosis, or facial nerve palsy.

Scientific Title:Acronym

Relationship between eyelid pressure and dry eye

Region

Japan


Condition

Condition

Thyroid eye disease, ptosis, and facial nerve palsy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the relationship between eyelid pressure and dry eye in patients with thyroid eye disease, ptosis, or facial nerve palsy.

Basic objectives2

Others

Basic objectives -Others

Thyroid eye disease and ptosis: To examine changes in eyelid pressure and the severity of dry eye after orbital decompression or levator advancement.
Facial nerve palsy: To examine the difference in eyelid pressure and the severity of dry eye between the affected and unaffected sides.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Eyelid pressure and the severity of dry eye (slitlamp examination, meibography, Schirmer test, OCT, and DEQS).
Thyroid eye disease and ptosis: Before and 3 months after the operation.
Facial nerve palsy: At the outpatient examination.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Thyroid eye disease: 30 patients. Each patient will undergo the examinations after consent to this study and postoperative 3 months follow-up.
Facial nerve palsy: 10 patients. Each patient will undergo the examinations after consent to this study.
Examinations: eyelid pressure and the severity of dry eye (slitlamp examination, meibography, Schirmer test, OCT, and DEQS).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 20 years or more.

Patients with consent to this study.

Key exclusion criteria

Patients without consent to this study.

Patients with history of eyelid or orbital surgery.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Takahashi

Organization

Aichi Medical University

Division name

Ophthalmology

Zip code

4801195

Address

1-1, Yazako-Karimata, Nagakute, Aichi, Japan

TEL

0561-62-3311

Email

yasuhiro_tak@yahoo.co.jp


Public contact

Name of contact person

1st name Yasuhiro
Middle name
Last name Takahashi

Organization

Aichi Medical University

Division name

Ophthalmology

Zip code

4801195

Address

1-1, Yazako-Karimata, Nagakute, Aichi, Japan

TEL

0561-62-3311

Homepage URL


Email

yasuhiro_tak@yahoo.co.jp


Sponsor or person

Institute

Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

The Ministry of Education, Culture, Sports, Science and Technology in Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi Medical University

Address

1-1 Yazakokarimata, Nagakute, Aichi, Japan

Tel

0561623311

Email

aichi-med@esct.bvits.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学病院(愛知県)/ Aichi Medical University Hospital (Aichi)


Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 07 Month 27 Day

Date of IRB

2015 Year 09 Month 05 Day

Anticipated trial start date

2015 Year 11 Month 11 Day

Last follow-up date

2017 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 04 Day

Last modified on

2023 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022695